Duchenne muscular dystrophy (DMD) is a severe muscle wasting disorder caused by
mutations in the dystrophin gene. To examine the influence of muscle structure on the …

Reducing the activity of cytokines and leukocyte extravasation is an emerging therapeutic
strategy to limit tissue‐damaging inflammatory responses and restore immune homeostasis …

Duchenne muscular dystrophy is caused by mutations in the DMD gene, leading to lack of
dystrophin. Chronic muscle damage eventually leads to histological alterations in skeletal …

Proteoglycans are ubiquitous dynamic molecules that are made up of a protein core to
which specific linear glycosylation structures, known as glycosaminoglycans, have been …

Aims Exogenously administered biglycan (core protein with high-molecular weight
glycosaminoglycan chains) has been shown to protect neonatal cardiomyocytes against …

Bone morphogenetic proteins (BMPs) function in most tissues but have cell type–specific
effects. Given the relatively small number of BMP receptors, this exquisite signaling …

We have used site-directed spin labeling and pulsed electron paramagnetic resonance to
resolve a controversy concerning the structure of the utrophin–actin complex, with …

Duchenne muscular dystrophy (DMD) is a muscle wasting disorder caused by mutations in
the DMD gene. Restoration of full-length dystrophin protein in skeletal muscle would have …

Background Duchenne muscular dystrophy (DMD) is a lethal X-linked muscle wasting
disorder caused by the absence of dystrophin, a large cytoskeletal muscle protein …

Duchenne muscular dystrophy (DMD) is a genetic and progressive neuromuscular disorder
caused by mutations and deletions in the dystrophin gene. Although there is currently no …